Raffles Medical Group Ltd (RAFLF)

Raffles Medical Group (RAFLF) Financial Statements


Raffles Medical Group Financial Overview

Raffles Medical Group's market cap is currently ―. The company's EPS TTM is $0.036; its P/E ratio is 20.44; and it has a dividend yield of 2.41%. Raffles Medical Group is scheduled to report earnings on July 29, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsS$ 253.13MS$ 289.07MS$ 264.99MS$ 215.74MS$ 203.11M
Total AssetsS$ 1.50BS$ 1.52BS$ 1.55BS$ 1.46BS$ 1.40B
Total DebtS$ 96.14MS$ 175.85MS$ 198.13MS$ 211.83MS$ 204.89M
Net DebtS$ -156.98MS$ -113.22MS$ -66.86MS$ -3.91MS$ 1.78M
Total LiabilitiesS$ 467.30MS$ 557.02MS$ 568.67MS$ 528.90MS$ 489.74M
Stockholders EquityS$ 1.02BS$ 945.75MS$ 960.79MS$ 910.83MS$ 899.00M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in SGD

Raffles Medical Group Earnings and Revenue History

Raffles Medical Group Debt to Assets

Raffles Medical Group Cash Flow

Raffles Medical Group Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis